Total Payments
$4,890
2024 Payments
$732.86
Companies
30
Transactions
244
Medicare Patients
4,866
Medicare Billing
$580,304
Payment Breakdown by Category
Food & Beverage$4,890 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,890 | 244 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $803.68 | 49 | $0 (2024) |
| Novo Nordisk Inc | $709.84 | 40 | $0 (2024) |
| Abbott Laboratories | $523.21 | 7 | $0 (2023) |
| Amgen Inc. | $419.92 | 24 | $0 (2024) |
| PFIZER INC. | $386.22 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $343.38 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $288.14 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $263.60 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $183.30 | 10 | $0 (2024) |
| ABBVIE INC. | $153.11 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $732.86 | 33 | Lilly USA, LLC ($184.17) |
| 2023 | $811.56 | 46 | Lilly USA, LLC ($209.45) |
| 2022 | $1,007 | 60 | Lilly USA, LLC ($190.91) |
| 2021 | $587.40 | 32 | PFIZER INC. ($115.89) |
| 2020 | $488.79 | 15 | Abbott Laboratories ($302.11) |
| 2019 | $623.96 | 25 | Abbott Laboratories ($147.44) |
| 2018 | $470.35 | 23 | Novo Nordisk Inc ($213.98) |
| 2017 | $168.59 | 10 | Lilly USA, LLC ($39.74) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Biological | ||||||
| 08/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: Cardio-renal | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Diabetes | ||||||
| 06/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Obesity | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: RESPIRATORY | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $122.30 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 04/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Obesity | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Inflammation | ||||||
| 03/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 876 | 1,353 | $165,685 | $103,452 |
| 2022 | 14 | 1,239 | 1,939 | $241,765 | $156,751 |
| 2021 | 17 | 1,468 | 2,284 | $268,320 | $174,333 |
| 2020 | 20 | 1,283 | 1,992 | $250,210 | $145,768 |
Total Patients
4,866
Total Services
7,568
Medicare Billing
$580,304
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 670 | $100,500 | $56,947 | 56.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 189 | 189 | $28,350 | $24,443 | 86.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 156 | $17,940 | $8,886 | 49.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 23 | $6,900 | $4,893 | 70.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 186 | 186 | $4,650 | $3,408 | 73.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $3,500 | $1,934 | 55.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 43 | 43 | $1,720 | $1,440 | 83.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $1,350 | $1,323 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 16 | $775.00 | $177.90 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 295 | 860 | $129,000 | $74,887 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 245 | 245 | $36,750 | $32,410 | 88.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 210 | $24,150 | $13,060 | 54.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 25 | 33 | $9,900 | $7,449 | 75.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 241 | 241 | $6,025 | $4,457 | 74.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 24 | 24 | $4,800 | $4,123 | 85.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 36 | 39 | $7,020 | $4,101 | 58.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 30 | 70 | $7,000 | $3,979 | 56.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 16 | 16 | $4,800 | $3,956 | 82.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $5,460 | $2,762 | 50.6% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $2,300 | $1,838 | 79.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $1,770 | $1,707 | 96.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 59 | 59 | $1,770 | $1,164 | 65.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 30 | 30 | $1,020 | $857.12 | 84.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 264 | 787 | $118,050 | $71,601 | 60.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 230 | 230 | $34,500 | $31,109 | 90.2% |
About Dr. Javier Canasi, MD
Dr. Javier Canasi, MD is a Internal Medicine healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396774584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Javier Canasi, MD has received a total of $4,890 in payments from pharmaceutical and medical device companies, with $732.86 received in 2024. These payments were reported across 244 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,890).
As a Medicare-enrolled provider, Canasi has provided services to 4,866 Medicare beneficiaries, totaling 7,568 services with total Medicare billing of $580,304. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Palm Beach Gardens, FL
- Active Since 07/01/2006
- Last Updated 05/17/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396774584
Products in Payments
- MOUNJARO (Drug) $429.06
- Confirm Rx (Device) $302.11
- Kerendia (Drug) $288.14
- TRULICITY (Drug) $283.65
- Ozempic (Drug) $225.99
- Saxenda (Drug) $207.28
- ENTRESTO (Drug) $186.11
- Otezla (Drug) $180.70
- ELIQUIS (Drug) $175.47
- TRELEGY ELLIPTA (Drug) $155.72
- Mitra Clip system (Device) $147.44
- Rybelsus (Drug) $141.99
- LEQVIO (Drug) $140.63
- UBRELVY (Drug) $132.35
- AIRSUPRA (Drug) $122.30
- NURTEC ODT (Drug) $116.93
- Repatha (Biological) $112.17
- Aimovig (Biological) $97.92
- NEXLETOL (Drug) $83.45
- XARELTO (Drug) $80.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Palm Beach Gardens
Dr. Ravi Pandey, Md, MD
Internal Medicine — Payments: $17,395
Internal Medicine $17,395
Dr. Rupesh Dharia, M.d, M.D
Internal Medicine — Payments: $15,087
Internal Medicine $15,087
Amir Fahmy, Md, MD
Internal Medicine — Payments: $12,315
Internal Medicine $12,315
Romel Arjona, M.d, M.D
Internal Medicine — Payments: $9,757
Internal Medicine $9,757
Alissa O'brien, M.d, M.D
Internal Medicine — Payments: $7,028
Internal Medicine $7,028
Yasmin Islam, Md, MD
Internal Medicine — Payments: $4,221
Internal Medicine $4,221